Full Text
Commercialising Regenerative Medicines in the US – What Lessons can We Learn from Europe?

Abstract

Authors

R Macaulay

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×